Theragenics Corp trades in the stock market as ticker TGX. Business Summary & Profile For Theragenics Corp.

Theragenics Corp

Theragenics Corporation operates as a medical device company serving the cancer treatment and surgical products markets primarily in the United States and Europe. It operates through two segments, Surgical Products and Brachytherapy Seed. The Surgical Products segment manufactures, markets, and sells disposable devices primarily utilized in surgical procedures. It offers wound closure products, including sutures, needles, and other surgical products; vascular access products comprising introducer sheaths, guidewires, and accessories; and specialty needles consisting of coaxial, biopsy, brachytherapy, guidewire introducer, spinal, and disposable veress, as well as access trocars and other needle-based products. This segmentÂ’s products are used in various markets and applications, such as interventional cardiology and radiology, vascular surgery, orthopedics, plastic surgery, urology, veterinary medicine, pain management, endoscopy, and spinal surgery. The Brachytherapy Seed segment manufactures, markets, and sells TheraSeed and I-Seed, which are FDA-cleared devices for treatment of solid localized tumors and localized prostate cancer. The company sells its products primarily to physicians, hospitals and other healthcare providers, original equipment manufacturers, and to a network of distributors. Theragenics Corporation was founded in 1981 and is based in Buford, Georgia.
www.theragenics.com
500 Employees
Last Reported Date: 02/25/11
Founded in 1981
LAST $1.55 USD
CHANGE TODAY -0.01 -0.64%
VOLUME 32.2K
As of 12:26 PM 02/27/12 All times are local (Market data is delayed by at least 15 minutes).

Snapshot of THERAGENICS CORP (TGX)

OPEN
$1.51
PREVIOUS CLOSE
$1.56
DAY HIGH
$1.55
DAY LOW
$1.49
52 WEEK HIGH
04/6/11 - $2.29
52 WEEK LOW
10/7/11 - $1.18
MARKET CAP
52.7M
AVERAGE VOLUME 10 D
48.6K
EPS TTM
$0.10
SHARES OUTSTANDING
34.0M
TGX Does Not Pay Dividends
P/E TTM
15.5x
K = Thousands  M = Millions  B = Billions

related news for THERAGENICS CORP (TGX)

Theragenics Among Leading NYSE Intra-Day Decliners

Key developments for THERAGENICS CORP (TGX)

Theragenics Corp. Reports Unaudited Consolidated Earnings Results for the Fourth Quarter and Full Year Ended December 31, 2011; Provides Capex Guidance for the Full Year of 2012

Theragenics Corp. reported unaudited consolidated earnings results for the fourth quarter and full year ended December 31, 2011. For the quarter, the company reported total revenues of $19,879,000 compared with $20,677,000 for the same period a year ago. Operating income of $569,000 compared with $506,000 for the same period a year ago. Earnings before income taxes of $442,000 compared with $601,000 for the same period a year ago. Net earnings of $280,000 or $0.01 per diluted share compared with $373,000 or $0.01 per diluted share for the same period a year ago. Adjusted EBITDA of $2,589,000 compared with $2,418,000 for the same period a year ago. For the full year, the company reported total revenues of $82,730,000 compared with $82,184,000 for the same period a year ago. Operating income of $5,496,000 compared with $3,886,000 for the same period a year ago. Earnings before income taxes of $4,966,000 compared with $3,303,000 for the same period a year ago. Net earnings of $3,064,000 or $0.09 per diluted share compared with $2,070,000 or $0.06 per diluted share for the same period a year ago. Adjusted EBITDA of $13,480,000 compared with $11,626,000 for the same period a year ago. The capital expenditures totaled $2 million for the year. The company expect its CapEx spend for 2012 to be similar to 2011 exclusive of the purchase price for the core asset acquisition.

Theragenics Corp. to Report Q4, 2011 Results on Feb 21, 2012

Theragenics Corp. announced that they will report Q4, 2011 results Pre-Market on Feb 21, 2012

Theragenics Corp., Q4 2011 Earnings Call, Feb 23, 2012

Theragenics Corp., Q4 2011 Earnings Call, Feb 23, 2012

TGX Competitors

Company Last Change
AngioDynamics Inc $13.17 USD -0.12
Eckert-Ziegler Bebig €2.02 EUR 0.00
Greatbatch Inc $25.44 USD +0.28
IsoRay Inc $0.58 USD 0.00
Merit Medical Systems Inc $12.54 USD +0.08
Market data is delayed at least 15 minutes.
 

Industry Analysis

Valuation TGX Industry Range
Price/Earnings 16.7x
Price/Sales 0.6x
Price/Book 0.6x
Price/Cash Flow 8.9x
TEV/Sales NM Not Meaningful

TGX

 | 

TGX transactions

Type
Date
Target
Merger/Acquisition
February 20, 2012
Core Oncology, Inc., Prostate Brachytherapy Customer Base
No related news found for this Theragenics Corp.

Write Comment Create Account
Subject Author
Six tight weekly closes!
Another tight weekly close. Last 6 weekly closes 1.63,1.62,1.63, 1.64, 1.62, 1.62. This has be...
lou62m
7 tight weekly closes
1.63,1.62,1.63, 1.64, 1.62, 1.62, 1.60. TGX will make a powerful move in one direction or the oth...
lou62m
No transaction today yet, what's going on?
If Yahoo Finance is correct there hasn't been a transaction in Theragenics today yet. Does a...
eddysurinx
TGX - C. R. Bard Inc. Earnings: Increased Costs Strains Margins as Profit Drops
Here's recent news mentioning TGX - "C. R. Bard Inc. Earnings: Increased Costs Stra...
deloranilsen
numbers can always be better
But for now the numbers are encouraging. BV growing and tangible BV still much higher than curr...
roadkillforbreakfast
profit focus
the 2010 10-K mentions a non-compete lawsuit filed against the former owners of CP Medical (almost 5...
krbpga
Comments from a shareholder
The transcript of TGX Q4 2011 earnings call has a very interesting part, when Jeff Anderson from Enc...
pinewood44
disconnect between CEO comp and shareholder returns
the CEO's salary has increased by 29% between 2005 (when we moved into surgical products) an...
krbpga
3d and 4th qtrs
financials for 3d and 4th qtrs should look very interesting with the new items being introduced and ...
apsjr
Good earnings!!
Core acquisition beginning to pay off. I expect strong earnings growth thru rest of 2012. Say hell...
lou62m
Slow Grind
The way this thing opended this am, it appears like its going to be a slow grind to reach and break ...
apsjr
Once eps is updated
from 0.09 to 0.11, we will see a move higher in stock price. Current p/e is 18.89, once eps is up...
lou62m
Obamacare effect
If the supremes declare all of obamacare unconstitutional, how much impact will that have on share p...
apsjr
If you like this space check out Isoray (ISR)
Watch the Discovery Channel video on Cesiun-131. It's the winner in this space and look at a...
dbaxter999
Theragenics buys ICUI Gets Off the J&J Hit List
Theragenics got on the J&J hit list by rejecting the J&J offer years ago. Since ICUI is b...
warrcee
Why haven't they fired the CEO?
The CEO getting paid $1 million a year, and some of the other higher ups are the only people making ...
sst_vandy_2000
I am here, is anyone else?
I am here, anyone else here? up to conversation? mussel...
ilikemybigballs
TGX eps 0.09 in 2011.
In qtr 1 2012, eps 0.03. My conservative estimate qtr 2 eps 0.04, qtr 3 0.04, qtr 4 0.04. 2012 ep...
lou62m
Once inventory is depleted
TGX is headed to 2.40. Only 400k shares sold and TGX will buy up more than 4m shares up to 2.40/sha...
lou62m
Over 1.5m shares
traded above 2 since Tuesday. Tender offer in effect thru July 11 2012. Anyone wanting out has the...
lou62m
I bet
TGX over the next few days moves right back up to 2.07...
lou62m
I decided to hold
all my shares. I will not tender any. It is possible we sell off after July 11, but IMO TGX will t...
lou62m
Over 3m shares
traded since TGX announced buyback between 2.00 - 2.40/share. At some point sellers will run out of...
lou62m
Anybody Having Fun Yet??
Everyone happy with the stock buyback?? I guess the long run will tell- but anyone who thinks that ...
hadenuffyet
Nice setup
There are short term technical indications suggesting TGX could make a move to higher levels. ( see ...
tbasshet

Quotes are delayed for NASDAQ, NYSE, OTC, OTCBB (Penny Stocks) and NYSE Amex when available. Quotes and other information supplied by independent providers and feeds. All information provided "as is" for informational purposes only, not intended for trading purposes or advice. Neither Localnewsnor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing Localnews, you agree not to redistribute the information found therein.

Privacy Policy - WE KEEP YOUR PERSONAL DATA PRIVATE AND CONFIDENTIAL - Localnews is committed to protecting the privacy of all our visitors and subscribers. Your right to privacy is very important to us. When you choose to provide us with information about yourself, we recognize that you trust us to act in a responsible manner. SHARING OF INFORMATION - Localnews does not sell, rent, lease or share any user information that it has collected over this website.

@2012 www.localnewsnow.org - Contact Us / Privacy Policy